REVersal of nEuromusculAr bLocking Agents in Patients Undergoing General Anaesthesia (REVEAL Study)

Background: Neuromuscular blocking agent (NMBA) monitoring and reversals are key to avoiding residual curarization and improving patient outcomes. Sugammadex is a NMBA reversal with favorable pharmacological properties. There is a lack of real-world data detailing how the diffusion of sugammadex aff...

Descripción completa

Detalles Bibliográficos
Autores principales: Greco, Massimiliano, Caruso, Pier Francesco, Angelotti, Giovanni, Aceto, Romina, Coppalini, Giacomo, Martinetti, Nicolò, Albini, Marco, Bash, Lori D., Carvello, Michele, Piccioni, Federico, Monzani, Roberta, Montorsi, Marco, Cecconi, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866312/
https://www.ncbi.nlm.nih.gov/pubmed/36675492
http://dx.doi.org/10.3390/jcm12020563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866312/
https://www.ncbi.nlm.nih.gov/pubmed/36675492
http://dx.doi.org/10.3390/jcm12020563

Ejemplares similares